Risk minimisation materials: Onivyde pegylated liposomal Irinotecan (4.3 mg/ml)

This formulation will be available on the UK market in Irish packaging from October 2020 to March 2021, due to supply issues with the UK packaging. There is no difference to the product inside the pack.

Source:

electronic Medicines compendium